1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.

Optogenetics to Treat Addiction, Brain Diseases, Mental Illness

By Hey :-), Jan 15, 2014 | |
  1. Hey :-)
    Exploring how dopamine neurones in the ventral tegmental area (VTA) of the brain influences alcohol drinking behaviours, a study at the University at Buffalo (UB), New York (US), has found that the emerging technique of optogenetics can stop binge drinking in rodents, suggesting gene therapy in the brain could be used to treat substance abuse, drug addiction, neurological diseases and mental illnesses.

    “We know that dopamine neurotransmission is linked to [alcohol drinking] behaviours, but we did not know how,” says Caroline E. Bass, PhD, Assistant Professor of Pharmacology and Toxicology in the UB School of Medicine and Biomedical Sciences. “Optogenetics allows us to stimulate the dopamine neurones directly, to see if dopamine release can actually modify drinking.” Optogenetics introduces a light-sensitive protein (opsin) into the neurone. When exposed to light the protein causes the neurone to fire and release neurotransmitter. “In this paper, one innovation is that we were able to target this light sensitive protein to only dopamine neurones,” Bass says. She is referring to the article “Optogenetic stimulation of VTA dopamine neurons reveals that tonic but not phasic patterns of dopamine transmission reduce ethanol self-administration,” published in Frontiers in Neuroscience, for which she served as first author.

    Bass has no doubt optogenetics has already “revolutionised” neuroscience. “We can now do more than just measure neurotransmitter release or neuronal activity when a behaviour is happening,” she says. “We can induce release and see if it actually causes a behaviour.”

    According to the pharmacology and toxicology expert, it is difficult to know which area of the brain is responsible for which behaviour. “Optogenetics allows us to parse this out,” says Bass. “We can stimulate a brain region to see how this alters behaviour and begin to map behaviours in a very precise way to the brain.” This ability to stimulate neurones with light could lead to better understanding of how to target these brain regions for developing treatments.

    Bass’ pioneering work could help propel optogenetics to the next level. “One of the important aspect of this study is showing how opsins can be targeted to specific neurones in normal animals,” she says, explaining that most previous optogenetics studies have used mutant mice that come pre-engineered with opsin-induced neurones. The UB team, however, used rats and were able to target the opsin only to dopamine neurones. “This is important because it opens up the field to other experimental models, and it gives us an avenue for targeting opsins to humans,” Bass interprets. “In the future we may be able to treat many dopamine-based disorders, including Parkinson's disease, schizophrenia and addiction using this technique.”

    In the study, the test animals, rats, were trained to drink alcohol in a way that mimics human binge-drinking behaviour. “I was most surprised that low-level dopamine release prevented the animals from drinking long after we stopped stimulating the neurones,” Bass says. “This points to a lot of potential behavioural mechanisms involved in how dopamine influences drinking.”

    Bass and her team still have many questions, such as which regions of the brain are most relevant to drinking alcohol? Would they see similar results with other drugs of abuse, such as cocaine? The team also want to extent their technique to targeting other types of neurones. “The brain is like a gigantic puzzle and it's tools like these that will help us put the pieces together,” Bass says. “We are on the cusp of truly transformative studies in neuroscience.”

    By Sandra Henderson, Research Editor
    January 15 2014
    Novus Light Technologies Today


To make a comment simply sign up and become a member!